Getting recognized the palmitoylation motif of APLNR, we developed a brief substrate sequence to competitively inhibit the palmitoylation of endogenous APLNR. This competitive peptide, which targets the APLNR palmitoylation web-site in combination with morphine, can inhibit the event of NCP, which include pain incidence, microglial activation, and inflammatory factor https://vonl145ezs2.wikisona.com/user